Mission Creek Capital Partners Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 79.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 631 shares of the healthcare conglomerate's stock after selling 2,413 shares during the quarter. Mission Creek Capital Partners Inc.'s holdings in UnitedHealth Group were worth $331,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the company. Oarsman Capital Inc. increased its holdings in shares of UnitedHealth Group by 4.7% in the first quarter. Oarsman Capital Inc. now owns 4,967 shares of the healthcare conglomerate's stock worth $2,602,000 after purchasing an additional 224 shares during the last quarter. Okabena Investment Services Inc. increased its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Okabena Investment Services Inc. now owns 4,504 shares of the healthcare conglomerate's stock worth $2,359,000 after purchasing an additional 64 shares during the last quarter. OMERS ADMINISTRATION Corp increased its stake in UnitedHealth Group by 57.3% during the first quarter. OMERS ADMINISTRATION Corp now owns 269,089 shares of the healthcare conglomerate's stock worth $140,935,000 after acquiring an additional 97,968 shares during the last quarter. Truvestments Capital LLC increased its stake in UnitedHealth Group by 6.9% during the first quarter. Truvestments Capital LLC now owns 636 shares of the healthcare conglomerate's stock worth $333,000 after acquiring an additional 41 shares during the last quarter. Finally, Wealth Preservation Advisors LLC bought a new stake in UnitedHealth Group during the first quarter worth approximately $218,000. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Stock Down 0.4%
Shares of NYSE UNH opened at $302.66 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $274.11 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.96 and a beta of 0.43. The stock has a 50 day moving average price of $288.01 and a 200 day moving average price of $383.24. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on UNH. Morgan Stanley reduced their price objective on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 20th. HSBC reissued a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Finally, Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $353.00.
Read Our Latest Analysis on UNH
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.